Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Physiological Therapy of Type 2 Diabetes - NovoRapid® FlexPen® Before Meals, Additionally Levemir® FlexPen® in the Evening or at Bedtime if Needed

NCT01487421 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01487421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01487421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Physiological Therapy of Type 2 Diabetes - NovoRapid® FlexPen® Before Meals, Additionally Levemir® FlexPen® in the Evening or at Bedtime if Needed
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
July 31, 2003
Completion date
October 31, 2006
Enrollment
2,134 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 2